We are bringing critical respiratory care technology and techniques to low and middle income communities who lack the infrastructure to manage and treat large scale Covid-19 related respiratory distress.
Hooded/Helmet Positive Airway Pressure (HPAP) ventilation techniques have been advanced in response to the Covid-19 pandemic with the introduction of the Subsalve Oxygen Treatment Hood. This device and technique allows for highly cost-effective non-invasive ventilation to ward off more severe respiratory distress.
The project has been supported by multiple individual donors, partners, both for-profit and not-for-profit companies and institutions, and has resulted in the provision of humanitarian aid to numerous countries including Bolivia, Honduras, Guatemala, Nicaragua, Mexico, Haiti, Nigeria, Indonesia, Iraq, and others. Covid-19 has just begun in many parts of the world – Help us Help.
…the helmets that your company [Subsalve] produces are fantastic and already saved and continue saving lives in Bolivia. Our physicians are more familiar and eager to use the device and share the benefits with other hospitals.
Approximately thirty to fifty percent of patients were successfully managed with helmet respiratory support, not requiring escalation to intubation and mechanical ventilation.
Early clinical trial results using our OXYJET coupled with the SUBSALVE OXYGEN TREATMENT HOOD have shown significant
improvement to oxygen saturation by greater than 11-percent within 15 minutes of initiating treatment.
Among patients with ARDS, treatment with helmet [hood] NIV resulted in a significant reduction of intubation rates.